Celldex Therapeutics
CLDX
#4572
Rank
A$2.66 B
Marketcap
$40.23
Share price
-0.68%
Change (1 day)
-3.02%
Change (1 year)

EPS for Celldex Therapeutics (CLDX)

EPS in 2023 (TTM): -$3.60

According to Celldex Therapeutics's latest financial reports the company's current EPS (TTM) is -$3.68. In 2022 the company made an earnings per share (EPS) of -$3.67 a decrease over its 2021 EPS that were of -$2.52.

EPS history for Celldex Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.60-1.75%
2022-$3.6745.73%
2021-$2.52-23.36%
2020-$3.28-41.05%
2019-$5.57-76.95%
2018-$24.1745.03%
2017-$16.66-42.54%
2016-$29.00-3.82%
2015-$30.15-0.76%
2014-$30.3829.41%
2013-$23.480%
2012-$23.48-9.73%
2011-$26.011312.5%
2010-$1.84-95.79%
2009-$43.70-49.64%
2008-$86.77-82.64%
2007-$499.91-44.98%
2006-$908.671270.83%
2005-$66.2933.33%
2004-$49.71-10%
2003-$55.24-16.67%
2002-$66.29-38.46%
2001-$107.71-4.88%
2000-$113.24-81.66%
1999-$617.29-87.2%
1998-$4,821206.39%
1997-$1,57313.02%
1996-$1,392

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$6.15 67.08%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.30-64.58%๐Ÿ‡บ๐Ÿ‡ธ USA
-$18.54 403.33%๐Ÿ‡บ๐Ÿ‡ธ USA
$21.71-689.58%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.85-177.50%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.37-245.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
-$0.87-76.25%๐Ÿ‡บ๐Ÿ‡ธ USA